Reopening America

Eli Lilly Monoclonal Antibody Drug Prevents COVID Infections in Nursing Homes

A study of nursing home residents found that a monoclonal antibody treatment made by Eli Lilly can cut the risk of Covid-19 by up to 80%. It is important to catch people at the early stages of infection and is meant for those that are high-risk patients. One of the difficulties in administering these drugs however is that it’s delivered via an hour-long infusion. Karen Weintruab, health reporter at USA Today, joins us for more. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.